{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:25:17Z","timestamp":1787023517642,"version":"build-2736575974"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374109"],"award-info":[{"award-number":["82374109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010876","name":"Shanghai University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010876","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymeth.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T05:47:23Z","timestamp":1780811243000},"page":"17-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A fluorescence-based high-content imaging workflow for multi-parametric lipid droplet phenotyping via Oil Red O fluorescence"],"prefix":"10.1016","volume":"254","author":[{"given":"Shaojun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.06.002_b0005","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymeth.2026.06.002_b0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons","volume":"79","author":"Le","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121185","article-title":"Shedding light on non-alcoholic fatty liver disease: Pathogenesis, molecular mechanisms, models, and emerging therapeutics","volume":"312","author":"Khairnar","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.ymeth.2026.06.002_b0020","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatol (baltim Md,)"},{"key":"10.1016\/j.ymeth.2026.06.002_b0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4254\/wjh.v5.i10.550","article-title":"Lipotoxicity in the liver","volume":"5","author":"Z\u00e1mb\u00f3","year":"2013","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ymeth.2026.06.002_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPG.0b013e31822578db","article-title":"Mechanisms of lipotoxicity in NAFLD and clinical implications","volume":"53","author":"Ibrahim","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymeth.2026.06.002_b0040","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1172\/JCI46069","article-title":"The role of lipid droplets in metabolic disease in rodents and humans","volume":"121","author":"Greenberg","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymeth.2026.06.002_b0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/emmm.201100671","article-title":"Balancing the fat: Lipid droplets and human disease","volume":"5","author":"Krahmer","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymeth.2026.06.002_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1083\/jcb.200502078","article-title":"Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type a scavenger receptor","volume":"171","author":"Devries-Seimon","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1039\/D1CC05717K","article-title":"Recent advances in fluorescent probes for lipid droplets","volume":"58","author":"Zhao","year":"2022","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.ymeth.2026.06.002_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2025.112792","article-title":"Recent advances in fluorescent probes for bioimaging lipid droplets associated diseases","volume":"239","author":"Jiang","year":"2025","journal-title":"Dyes Pigm."},{"key":"10.1016\/j.ymeth.2026.06.002_b0065","article-title":"Deep learning for bioimage analysis in developmental biology","volume":"148","author":"Hallou","year":"2021","journal-title":"Dev (camb Engl)"},{"key":"10.1016\/j.ymeth.2026.06.002_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149931","article-title":"Reference genes for quantitative real-time polymerase chain reaction in in vitro non-alcoholic fatty liver disease","volume":"979","author":"Chen","year":"2026","journal-title":"Gene"},{"key":"10.1016\/j.ymeth.2026.06.002_b0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nature06928","article-title":"Functional genomic screen reveals genes involved in lipid-droplet formation and utilization","volume":"453","author":"Guo","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.06.002_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101115","article-title":"Hepatic lipid droplets: a balancing act between energy storage and metabolic dysfunction in NAFLD","volume":"50","author":"Mashek","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymeth.2026.06.002_b0085","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jhep.2021.11.009","article-title":"A new perspective on NAFLD: focusing on lipid droplets","volume":"76","author":"Scorletti","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0090","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/s41556-024-01364-4","article-title":"Lipid droplets and cellular lipid flux","volume":"26","author":"Mathiowetz","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0095","first-page":"111","article-title":"Pharmacological PPAR\u03b2\/\u03b4 activation upregulates VLDLR in hepatocytes","volume":"31","author":"Zarei","year":"2019","journal-title":"Clin Investig Arterioscler: Publ of Soc Esp Arterioscler"},{"key":"10.1016\/j.ymeth.2026.06.002_b0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPAR\u03b2\/\u03b4 and FGF21 modulates non-alcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymeth.2026.06.002_b0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.fct.2018.02.019","article-title":"Quercetin ameliorates HFD-induced NAFLD by promoting hepatic VLDL assembly and lipophagy via the IRE1a\/XBP1s pathway","volume":"114","author":"Zhu","year":"2018","journal-title":"Food Chem Toxicol: Int J Publ Br Ind Biol Res Assoc"},{"key":"10.1016\/j.ymeth.2026.06.002_b0110","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.tcb.2020.09.006","article-title":"Lipid metabolism in regulation of macrophage functions","volume":"30","author":"Yan","year":"2020","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0115","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chembiol.2021.01.016","article-title":"Reimagining dots and dashes: visualizing structure and function of organelles for high-content imaging analysis","volume":"28","author":"Chin","year":"2021","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0120","article-title":"Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymeth.2026.06.002_b0125","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1111\/1750-3841.15475","article-title":"Ursolic acid alleviates lipid accumulation by activating the AMPK signaling pathway in vivo and in vitro","volume":"85","author":"Cheng","year":"2020","journal-title":"J. Food Sci."},{"key":"10.1016\/j.ymeth.2026.06.002_b0130","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1039\/C5FO00083A","article-title":"Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress","volume":"6","author":"Li","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.ymeth.2026.06.002_b0135","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.phymed.2016.07.001","article-title":"Target molecules in 3T3-L1 adipocytes differentiation are regulated by maslinic acid, a natural triterpene from olea europaea","volume":"23","author":"P\u00e9rez-Jim\u00e9nez","year":"2016","journal-title":"Phytomed: Int J Phytother Phytopharm"},{"key":"10.1016\/j.ymeth.2026.06.002_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120634","article-title":"Protective effects of maslinic acid on high fat diet-induced liver injury in mice","volume":"301","author":"Li","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.ymeth.2026.06.002_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157271","article-title":"Alisol a 24-acetate protects against NASH-associated fibrosis via suppression of kupffer cell-derived SPHK1\/S1P axis","volume":"148","author":"Zhang","year":"2025","journal-title":"Phytomed: Int J Phytother Phytopharm"},{"key":"10.1016\/j.ymeth.2026.06.002_b0150","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/nu14122411","article-title":"Alisol B alleviates hepatocyte lipid accumulation and lipotoxicity via regulating RAR\u03b1-PPAR\u03b3-CD36 cascade and attenuates non-alcoholic steatohepatitis in mice","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymeth.2026.06.002_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8857687","article-title":"Alismatis rhizoma triterpenes alleviate high-fat diet-induced insulin resistance in skeletal muscle of mice","volume":"2021","author":"Jia","year":"2021","journal-title":"Evid-Based Complement Altern Med: Ecam"},{"key":"10.1016\/j.ymeth.2026.06.002_b0160","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1159\/000452560","article-title":"Alisol a 24-acetate prevents hepatic steatosis and metabolic disorders in HepG2 cells","volume":"40","author":"Zeng","year":"2016","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ymeth.2026.06.002_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/aps.2016.119","article-title":"Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation","volume":"38","author":"Meng","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ymeth.2026.06.002_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177817","article-title":"Glycyrrhizic acid mitigates hepatocyte steatosis and inflammation through ACE2 stabilization via dual modulation of AMPK activation and MDM2 inhibition","volume":"1002","author":"Zhou","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0175","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation","volume":"46","author":"Yan","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymeth.2026.06.002_b0180","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/jpp\/rgad052","article-title":"Pharmacological properties and derivatives of saikosaponins-a review of recent studies","volume":"75","author":"Zhu","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0185","first-page":"1360","article-title":"The hypolipidemic effect of atractylenolide on obese zebrafish","volume":"46","author":"Wang","year":"2024","journal-title":"Chinese Traditional Patent Medicine"},{"key":"10.1016\/j.ymeth.2026.06.002_b0190","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jep.2018.08.023","article-title":"The traditional uses, phytochemistry, and pharmacology of atractylodes macrocephala koidz.: a review","volume":"226","author":"Zhu","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2025.101318","article-title":"Unlocking the potential of atractylenolide II: mitigating non-alcoholic fatty liver disease through farnesoid X receptor-endoplasmic reticulum stress interplay","volume":"15","author":"Gu","year":"2025","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ymeth.2026.06.002_b0200","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ymeth.2026.06.002_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154632","article-title":"Tanshinone I: Pharmacological activities, molecular mechanisms against diseases and future perspectives","volume":"110","author":"Ke","year":"2023","journal-title":"Phytomed: Int J Phytother Phytopharm"},{"key":"10.1016\/j.ymeth.2026.06.002_b0210","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1177\/0300060519859750","article-title":"Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4","volume":"47","author":"Huang","year":"2019","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.ymeth.2026.06.002_b0215","article-title":"\u03b2-sitosterol alleviated HFD-induced atherosclerosis by regulating the MAPK\/Nrf2\/NLRP3 pathway in ApoE-\/- mice","volume":"20","author":"Wu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ymeth.2026.06.002_b0220","doi-asserted-by":"crossref","unstructured":"Liu ZL, Xie LZ, Zhu J, et al. Herbal medicines for fatty liver diseases. Cochrane Database Syst Rev 2013:CD009059. https:\/\/doi.org\/10.1002\/14651858.CD009059.pub2.","DOI":"10.1002\/14651858.CD009059.pub2"},{"key":"10.1016\/j.ymeth.2026.06.002_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1554850","article-title":"Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPAR\u03b1","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2025.116178","article-title":"Multi-omics joint analysis: pachymic acid ameliorated non-alcoholic fatty liver disease by regulating gut microbiota","volume":"209","author":"Ren","year":"2025","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ymeth.2026.06.002_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007274","article-title":"Effects of poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR\/PPAR\u03b1-SREBPs pathway","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0240","article-title":"The action of poria cocos polysaccharides against non-alcoholic fatty liver disease: a preliminary study","volume":"8","author":"Zhou","year":"2025","journal-title":"Food Hydrocoll Health"},{"key":"10.1016\/j.ymeth.2026.06.002_b0245","article-title":"In vivo identification of bioactive components of poria cocos for adjusting mitochondria against metabolic dysfunction-associated fatty liver disease","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ymeth.2026.06.002_b0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ymeth.2026.06.002_b0255","article-title":"Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease","volume":"S2090","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ymeth.2026.06.002_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2021.109019","article-title":"Luteolin alleviates non-alcoholic fatty liver disease in rats via restoration of intestinal mucosal barrier damage and microbiota imbalance involving in gut-liver axis","volume":"711","author":"Liu","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ymeth.2026.06.002_b0265","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.intimp.2017.05.026","article-title":"Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries","volume":"49","author":"Liu","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0270","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1002\/ptr.7762","article-title":"Baicalin ameliorates high fat diet-induced nonalcoholic fatty liver disease in mice via adenosine monophosphate-activated protein kinase-mediated regulation of SREBP1\/Nrf2\/NF-\u03baB signaling pathways","volume":"37","author":"Gao","year":"2023","journal-title":"Phytother Res: Ptr"},{"key":"10.1016\/j.ymeth.2026.06.002_b0275","article-title":"Puerarin ameliorates non-alcoholic fatty liver disease by inhibiting lipid metabolism through FMO5","volume":"15","author":"Li","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0280","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1039\/C3FO60524H","article-title":"A diet formula of puerariae radix, lycium barbarum, crataegus pinnatifida, and polygonati rhizoma alleviates insulin resistance and hepatic steatosis in CD-1 mice and HepG2 cells","volume":"5","author":"Liu","year":"2014","journal-title":"Food Funct."},{"key":"10.1016\/j.ymeth.2026.06.002_b0285","unstructured":"Zhang Qi, Wang Yan, Xiong Qingfang, et al. Liquiritin ameliorates palmitic acid-induced hepatic steatosis in mouse primary hepatocytes by suppressing the VEGFA signaling pathway. Journal of Food Biochemistry n.d."},{"key":"10.1016\/j.ymeth.2026.06.002_b0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12906-016-0997-0","article-title":"Hepatoprotective effect of licorice, the root of glycyrrhiza uralensis fischer, in alcohol-induced fatty liver disease","volume":"16","author":"Jung","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ymeth.2026.06.002_b0295","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.18632\/aging.203817","article-title":"Hesperidin suppresses ERS-induced inflammation in the pathogenesis of non-alcoholic fatty liver disease","volume":"14","author":"Xie","year":"2022","journal-title":"Aging (Milano)"},{"key":"10.1016\/j.ymeth.2026.06.002_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41387-020-00130-3","article-title":"Neohesperidin enhances PGC-1\u03b1-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice","volume":"10","author":"Wang","year":"2020","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.ymeth.2026.06.002_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2023.105578","article-title":"Naringenin prevents NAFLD in the diet-induced C57BL\/6J obesity model by regulating the intestinal barrier function and microbiota","volume":"105","author":"Yu","year":"2023","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.ymeth.2026.06.002_b0310","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by enhancing energy expenditure and regulating autophagy via AMPK","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0315","article-title":"Aurantio-obtusin attenuates non-alcoholic fatty liver disease through AMPK-mediated autophagy and fatty acid oxidation pathways","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0320","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12967-022-03495-4","article-title":"Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome","volume":"20","author":"Wu","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ymeth.2026.06.002_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105704","article-title":"Active ingredients of erhuang quzhi granules for treating non-alcoholic fatty liver disease based on the NF-\u03baB\/NLRP3 pathway","volume":"171","author":"Li","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ymeth.2026.06.002_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114340","article-title":"Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway","volume":"279","author":"Shen","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0335","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s10020-025-01304-4","article-title":"Rhein alleviates hepatic steatosis in NAFLD mice by activating the AMPK\/ACC\/SREBP1 pathway to enhance lipid metabolism","volume":"31","author":"Dai","year":"2025","journal-title":"Mol Med (camb Mass,)"},{"key":"10.1016\/j.ymeth.2026.06.002_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109099","article-title":"Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob\/ob mice","volume":"111","author":"Meng","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0345","article-title":"Activation of TAF9 via danshensu-induced upregulation of HDAC1 expression alleviates non-alcoholic fatty liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110461","article-title":"Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS\/TLR4\/MyD88 signaling pathway","volume":"376","author":"Gu","year":"2023","journal-title":"Chem-Biol Interact"},{"key":"10.1016\/j.ymeth.2026.06.002_b0355","article-title":"Geniposide and chlorogenic acid combination improves non-alcoholic fatty liver disease involving the potent suppression of elevated hepatic SCD-1","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.06.002_b0360","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1159\/000495898","article-title":"Resveratrol ameliorates lipid droplet accumulation in liver through a SIRT1\/ ATF6-dependent mechanism","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ymeth.2026.06.002_b0365","article-title":"Berberine attenuates nonalcoholic hepatic steatosis by regulating lipid droplet-associated proteins: Invivo, invitro and molecular evidence","volume":"29","author":"Wang","year":"2025","journal-title":"J. Cell Mol. Med."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:12Z","timestamp":1787021232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":73,"alternative-id":["S1046202326001489"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.06.002","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A fluorescence-based high-content imaging workflow for multi-parametric lipid droplet phenotyping via Oil Red O fluorescence","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}